[1]叶 健,席 鑫,汪 谞,等.急性前壁心肌梗死PCI术后肾动脉去交感神经术对心功能影响的临床研究[J].介入放射学杂志,2022,31(06):550-554.
 YE Jian,XI Xin,WANG Xu,et al.The effect of renal denervation on cardiac function in patients with acute anterior wall myocardial infarction after percutaneous coronary intervention: a clinical study[J].journal interventional radiology,2022,31(06):550-554.
点击复制

急性前壁心肌梗死PCI术后肾动脉去交感神经术对心功能影响的临床研究()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
31
期数:
2022年06
页码:
550-554
栏目:
心脏介入
出版日期:
2022-07-31

文章信息/Info

Title:
The effect of renal denervation on cardiac function in patients with acute anterior wall myocardial infarction after percutaneous coronary intervention: a clinical study
作者:
叶 健 席 鑫 汪 谞 郜俊清 刘宗军
Author(s):
YE Jian XI Xin WANG Xu GAO Junqing LIU Zongjun.
Department of Cardiology, Affiliated Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200062, China
关键词:
【关键词】 肾动脉去交感神经术 急性前壁心肌梗死 心功能 心肺运动试验
文献标志码:
A
摘要:
【摘要】 目的 观察肾动脉去交感神经术(RDN)改善急性心肌梗死(AMI)患者PCI术后心功能的效果和安全性。 方法 选取2019年1月至2020年12月上海市普陀区中心医院收治的急性前壁ST段抬高型心肌梗死并接受急诊经皮冠状动脉介入治疗(PCI)后4周左心室收缩活动异常的患者。按随机数字法将患者分为对照组和RDN组。对照组PCI后常规药物治疗,RDN组PCI后在药物治疗础上接受RDN术。对比两组随访时心脏超声检查、心肺运动试验、诊室血压、心率检查结果。结果 共纳入108例患者,每组54例。两组间基线资料差异无统计学意义(P>0.05)。随访6个月,RDN组左心室射血分数[(57.14±6.78)%比(47.89±9.12)%]、左心室收缩末期内径[(34.26±5.61) mm比(37.84±7.21) mm]、左心室缩短分数[(30.82±4.80)%比(27.30±6.95)%]、左心房内径[(36.68±5.17) mm比(39.24±4.67) mm]与对照组相比明显改善,差异有统计学意义(均P<0.05);RDN组最大摄氧量[(22.29±4.50) mL?kg-1?min-1比(19.95±4.56) mL?kg-1?min-1]、代谢当量(6.37±1.29比5.70±1.30)、最大心率[(139.35±19.02) bpm比(128.17±16.33) bpm]及半分钟心率[(82.33±11.45) bpm比(87.65±12.25) bpm]与对照组相比,差异有统计学意义(均P<0.05);两组患者间诊室血压、心率及血肌酐差异无统计学意义(均P>0.05)。 结论 RDN术可改善AMI患者PCI术后心肺功能,提高患者生活质量。

参考文献/References:

[1] 《中国心血管健康与疾病报告》编写组. 《中国心血管健康与疾病报告2020》概述[J]. 中国心血管病研究, 2021, 19:582-590.
[2] O’gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST- elevation myocardial infarction: executive summary[J]. J Am Coll Cardiol, 2013, 61: 485-510.
[3] Faridi KF, Bhalla N, Atreja N, et al. New heart failure after myocardial infarction(from the National Cardiovascular Data Registries[NCDR] linked with all- payer claims)[J]. Am J Cardiol, 2021, 151: 70-77.
[4] Urbancsek R, Csanadi Z, Forgacs IN, et al. Sympathetic activation in heart failure with reduced and mildly reduced ejection fraction: the role of aetiology[J]. ESC Heart Fail, 2021, 8: 5112-5120.
[5] Bazoukis G, Thomopoulos C, Tse G, et al. Impact of renal sympathetic denervation on cardiac magnetic resonance- derived cardiac indices in hypertensive patients: a meta- analysis[J]. J Cardiol, 2021, 78: 314-321.
[6] Pan T, Zhang Q, Denervation GE. From hypertension to non-hypertension diseases[J]. J Intervent Med, 2021, 4: 130-135.
[7] 唐敏娜,胡嘉禄,颜 彦. 去肾神经术(RD)对比药物治疗急性心梗(AMI)后心衰(HF)大鼠的疗效及机制[J]. 复旦学报(医学版), 2019, 46:584-591.
[8] Grassi G, Mancia G, Esler M. Central and peripheral sympathetic activation in heart failure[J]. Cardiovasc Res, 2022, 118:1857-1871.
[9] 武智晓,王 璐,李 杰,等. 罪犯血管类型与STEMI患者早期自主神经功能关系研究[J]. 中国医学工程, 2021, 29:105-108.
[10] 黄 洁,裴晏梓,刘 阳,等. 哌唑嗪(PRA)拮抗去甲肾上腺素(NE)诱导人类胚胎干细胞来源的心肌细胞(hESCs-CMs)肥大[J]. 复旦学报(医学版), 2019, 46:309-315.
[11] Fudim M, Ponikowski PP, Burkhoff D, et al. Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations[J]. Eur J Heart Fail, 2021, 23: 1076-1084.
[12] Tian H, Yu D, Hu Y, et al. Angiotensin Ⅱ upregulates cyclophilin A by enhancing ROS production in rat cardiomyocytes[J]. Mol Med Rep, 2018, 18: 4349-4355.
[13] Prathapan A, Salin Raj P, Priya Rani M, et al. Apoptosis in angiotensin Ⅱ- stimulated hypertrophic cardiac cells- modulation by phenolics rich extract of Boerhavia diffusa L[J]. Biomed Phar-macother, 2018, 108:1097-1104.
[14] Zhang X, Zheng C, Gao Z, et al. SLC7A11/xCT prevents cardiac hypertrophy by inhibiting ferroptosis[J]. Cardiovasc Drugs Ther, 2022, 36:437- 447.
[15] Sharma NM, Haibara AS, Katsurada K, et al. Central Ang Ⅱ (angiotensin Ⅱ)- mediated sympathoexcitation: role for HIF-1α (hypoxia-inducible factor-1α) facilitated glutamatergic tone in the paraventricular nucleus of the hypothalamus[J]. Hypertension, 2021, 77: 147-157.
[16] Yamaki F, Obara K, Tanaka Y. Angiotensin Ⅱ regulates excitability and contractile functions of myocardium and smooth muscles through autonomic nervous transmission[J]. Yakugaku Zasshi, 2019, 139:793-805.
[17] Bitar S, Thilly N, Agrinier N. Prognostic association of medication trajectories with 3-year mortality in heart failure and preserved ejection fraction: findings from the EPICAL2 cohort study[J]. Eur J Clin Pharmacol, 2021, 77: 1569-1581.
[18] Vaduganathan M, Fonarow GC, Greene SJ, et al. Treatment persistence of renin-angiotensin- aldosterone- system inhibitors over time in heart failure with reduced ejection fraction[J]. J Card Fail, 2021: S1071-9164(21)00341-9.
[19] 匡丽萍,单春燕. 心力衰竭治疗药物研究进展[J]. 慢性病学杂志, 2020, 21:1656-1659.
[20] Heusser K, Wittkoepper J, Bara C, et al. Sympathetic vasocon-strictor activity before and after left ventricular assist device implantation in patients with end- stage heart failure[J]. Eur J Heart Fail, 2021, 23: 1955-1959.
[21] Malek F, Gajewski P, Zymliński R, et al. Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first- in- human clinical trial[J]. Eur J Heart Fail, 2021, 23: 1134-1143.
[22] Hearon CM, Howden EJ, Fu Q, et al. Evidence of reduced efferent renal sympathetic innervation after chemical renal denervation in humans[J]. Am J Hypertens, 2021, 34: 744-752.
[23] Nishihara M, Takesue K, Hirooka Y. Renal denervation enhances GABA- ergic input into the PVN leading to blood pressure lowering in chronic kidney disease[J]. Auton Neurosci, 2017, 204: 88-97.
[24] 王 彬,王海昌,薛玉生,等. 肾脏去交感神经对肥胖型高血压家兔血压及相关神经体液因子的影响[J]. 山西医科大学学报, 2016, 47:703-705.
[25] Kresoja KP, Rommel KP, Fengler K, et al. Renal sympathetic denervation in patients with heart failure with preserved ejection fraction[J]. Circ Heart Fail, 2021, 14: e7421.
[26] Han W, Wang M, Zhai X, et al. Chemical renal denervation-induced upregulation of the ACE2/Ang(1-7)/Mas axis attenuates blood pressure elevation in spontaneously hypertensive rats[J]. Clin Exp Hypertens, 2020, 42: 661-668.
[27] Lian Z, Yu SR, Song JX, et al. Efficacy and safety of catheter-based renal denervation for heart failure with reduced ejection fraction: a systematic review and meta-analysis[J]. Clin Auton Res, 2020, 30: 521-530.
[28] Geng J, Chen C, Zhou X, et al. Influence of renal sympathetic denervation in patients with early- stage heart failure versus late-stage heart failure[J]. Int Heart J, 2018, 59: 99-104.
[29] Chen W, Ling Z, Xu Y, et al. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: a prospective, randomized, controlled, pilot study[J]. Catheter Cardiovasc Interv, 2017, 89: E153- E161.
[30] Cokkinos DV, Belogianneas C. Left ventricular remodelling: a problem in search of solutions[J]. Eur Cardiol, 2016, 11: 29-35.
[31] Wang L, Wei G, Song L, et al. Effect of renal sympathetic denerzvation on ventricular and neural remodeling[J]. Herz, 2019, 44: 717-725.
[32] Li C, Xia W, Wang L, et al. Effect of renal denervation on cardiac function and inflammatory factors in heart failure after myo-cardial infarction[J]. J Cardiovasc Pharmacol, 2020, 76: 602-609.
[33] 苟春丽,刘永铭,薛丽丽,等. 射血分数中间型心力衰竭患者的临床特征及心脏结构功能变化[J]. 临床心血管病杂志, 2021,37:541-546.
[34] Gao JQ, Yang W, Liu ZJ. Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial[J]. Cardiol J, 2019, 26: 503-510.
[35] Tanaka S, Miyamoto T, Mori Y, et al. Heart rate recovery is useful for evaluating the recovery of exercise tolerance in patients with heart failure and atrial fibrillation[J]. Heart Vessels, 2021, 36: 1551-1557.
[36] Dupuy A, Birat A, Maurelli O, et al. Post-exercise heart rate recovery and parasympathetic reactivation are comparable between prepubertal boys and well-trained adult male endurance athletes[J]. Eur J Appl Physiol, 2022, 122: 345-355.
[37] Wei S, Li D, Zhang Y, et al. Perivascular radiofrequency renal denervation lowers blood pressure and ameliorates cardiorenal fibrosis in spontaneously hypertensive rats[J]. PLoS One, 2017, 12: e0176888.
[38] Bohm M, Ferreira JP, Mahfoud F, et al. Myocardial reperfusion reverses the J- curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trial[J]. Eur Heart J, 2020, 41: 1673-1683.

相似文献/References:

[1]金惠根,李京波,陆志刚,等.冠脉支架内血栓形成致急性心肌梗死[J].介入放射学杂志,2000,(01):27.

备注/Memo

备注/Memo:
(收稿日期:2021-12-12)
(本文编辑:边 佶)
更新日期/Last Update: 2022-07-27